Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Prognostic Value of Ki-67, p53, Epidermal Growth Factor Receptor, 1p36, 9p21, 10q23, and 17p13 in Skull Base Chordomas

1 Aug 2010

Abstract excerpt

CONTEXT: Skull base chordomas are rare, locally aggressive, notochord-derived neoplasms for which prognostically relevant biomarkers are not well established. OBJECTIVE: To evaluate whether newly discovered molecular alterations in chordomas have prognostic significance similar to what has been described regarding Ki-67 proliferation index. DESIGN: We conducted a retrospective study of 28 cases of primary clival...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Tumor Diagnosis and Treatments
Share to Head and Neck Surgical Oncology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20670138
DOI: 10.5858/2009-0380-oa.1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Prognostic Value of Ki-67, p53, Epidermal Growth Factor Receptor, 1p36, 9p21, 10q23, and 17p13 in Skull Base ChordomasPMID 20670138Read ↗

Prospective validation of a molecular prognostication panel for clival chordomaSemantic proximity Read ↗

Evaluation of 1p36 markers and clinical outcome in a skull base chordoma studySemantic proximity Read ↗

High-resolution whole-genome analysis of skull base chordomas implicates FHIT loss in chordoma pathogenesis.Semantic proximity Read ↗

Unraveling molecular advancements in chordoma tumorigenesis and treatment response: a review of scientific discoveries and clinical implicationsSemantic proximity Read ↗

Methylation-based reclassification and risk stratification of skull-base chordomasSemantic proximity Read ↗

Chordoma: Genetics and Contemporary Management.Semantic proximity Read ↗

Mutational analysis of primary and advanced chordoma tissue using next‐generation sequencingSemantic proximity Read ↗

The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkersSemantic proximity Read ↗

An Integrated Management Paradigm for Skull Base Chordoma Based on Clinical and Molecular CharacteristicsSemantic proximity Read ↗

Genome‐wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U‐CH1Semantic proximity Read ↗

TP53 Mutations as Drivers of Chordoma Progression and Hallmarks of Aggressive ChordomaSemantic proximity Read ↗

Genomic and transcriptomic characterization of skull base chordomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.